AorticPhlex

Mission: AorticPhlex is revolutionizing the treatment of aortic regurgitation (AR) by developing a cost-effective, minimally invasive, and anatomically adaptive annuloplasty ring. Our device is designed to preserve native valve function while improving long-term outcomes for patients globally. Vision: We aim to establish the expansive open annuloplasty ring as the gold standard in aortic valve repair—offering an alternative to replacement that addresses the unmet needs of millions of patients and reduces reliance on lifelong anticoagulation and reoperations. What We Do: Our technology is a flexible, biocompatible, and surgeon-friendly annuloplasty ring that stabilizes and reshapes the aortic annulus to restore valve competence. It’s modular, expandable, and adaptable to both bicuspid and tricuspid valve anatomies. The ring is optimized for minimally invasive procedures and integrates seamlessly with modern surgical workflows. The Problem We Solve: More than 10 million people suffer from severe aortic regurgitation globally. Despite many being eligible for repair, valve replacement remains dominant due to the lack of repair-focused solutions. AorticPhlex bridges this gap with a scalable, repair-first device that reduces surgical burden and improves long-term outcomes. Why It Matters: By preserving the native valve, patients avoid complications tied to mechanical or bioprosthetic valves—especially bleeding risks, valve degeneration, and lifelong anticoagulation. Our solution is not only better for patients but also significantly reduces costs for hospitals and health systems.